A detailed history of Cordasco Financial Network transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Cordasco Financial Network holds 100 shares of AXSM stock, worth $8,985. This represents 0.0% of its overall portfolio holdings.

Number of Shares
100
Holding current value
$8,985
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 15, 2022

BUY
$21.74 - $46.75 $2,174 - $4,675
100 New
100 $4,000

Others Institutions Holding AXSM

About Axsome Therapeutics, Inc.


  • Ticker AXSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,878,000
  • Market Cap $3.85B
  • Description
  • Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...
More about AXSM
Track This Portfolio

Track Cordasco Financial Network Portfolio

Follow Cordasco Financial Network and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cordasco Financial Network, based on Form 13F filings with the SEC.

News

Stay updated on Cordasco Financial Network with notifications on news.